A randomised, double-blind, comparison of the efficacy and safety of venlafaxine (75 to 150 mg/day) versus fluoxetine (20 mg/day) in depressed outpatients

Author： Salinas E.   Nicholas T.   Hackett D.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 308-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of 24 Weeks of Therapy with Bendroflumethiazide 1.25 mg/day or 2.5 mg/day and Potassium Chloride Compared with Enalapril 10 mg/day and Amlodipine 5 mg/day in Patients with Mild to Moderate Primary Hypertension: A Multicentre, Randomised, Open Study

By Rasmussen S.  

Clinical Drug Investigation, Vol. 26, Iss. 2, 2006-01 ,pp. : 91-101

Adis International

Access to resources Recommend Favorite

Remission Rates with Milnacipran 100 Mg/Day and 150 Mg/Day in the Long-Term Treatment of Major Depression

By Okumura Kazuo  

Clinical Drug Investigation, Vol. 26, Iss. 3, 2006-01 ,pp. : 135-142

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability Comparison of Ebastine 10 and 20mg with Loratadine 10mg: A Double-Blind, Randomised Study in Patients with Perennial Allergic Rhinitis

By Davies R.J.  

Clinical Drug Investigation, Vol. 16, Iss. 6, 1998-12 ,pp. : 413-420

Adis International

Access to resources Recommend Favorite

Prednisone doses of < 7.5 mg/day are not associated with excess herpes zoster risk

By  

Reactions Weekly, Vol. 1, Iss. 1281, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Efficacy of Tamsulosin 0.4 mg/day in Relieving Double-J Stent-related Symptoms: a Randomized Controlled Study

By Navanimitkul N   Lojanapiwat B  

The Journal of International Medical Research, Vol. 38, Iss. 4, 2010-07 ,pp. : 1436-1441

Field House Publishing

Access to resources Recommend Favorite